SE7811193L - Farmaceutiska preparat - Google Patents

Farmaceutiska preparat

Info

Publication number
SE7811193L
SE7811193L SE7811193A SE7811193A SE7811193L SE 7811193 L SE7811193 L SE 7811193L SE 7811193 A SE7811193 A SE 7811193A SE 7811193 A SE7811193 A SE 7811193A SE 7811193 L SE7811193 L SE 7811193L
Authority
SE
Sweden
Prior art keywords
pharmaceuticals
Prior art date
Application number
SE7811193A
Other languages
English (en)
Other versions
SE433304B (sv
Inventor
K Bernauer
H Link
H Stohler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH546578A external-priority patent/CH642944A5/de
Priority claimed from CH546678A external-priority patent/CH639846A5/de
Priority claimed from CH940778A external-priority patent/CH644850A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7811193L publication Critical patent/SE7811193L/sv
Publication of SE433304B publication Critical patent/SE433304B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SE7811193A 1977-10-28 1978-10-27 Farmaceutiska preparat med terapeutiska, speciellt anti- androgena och schistosomicida egenskaper SE433304B (sv)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
LU78408 1977-10-28
LU78407 1977-10-28
CH546578A CH642944A5 (en) 1978-05-19 1978-05-19 Urea derivatives
CH546678A CH639846A5 (en) 1978-05-19 1978-05-19 Pharmaceutical preparations having antiandrogenic action, containing urea derivatives or hydantoin derivatives
CH940778A CH644850A5 (en) 1977-10-28 1978-09-07 Pharmaceutical preparations containing urea derivatives

Publications (2)

Publication Number Publication Date
SE7811193L true SE7811193L (sv) 1979-04-29
SE433304B SE433304B (sv) 1984-05-21

Family

ID=27509239

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7811193A SE433304B (sv) 1977-10-28 1978-10-27 Farmaceutiska preparat med terapeutiska, speciellt anti- androgena och schistosomicida egenskaper
SE8202106A SE8202106L (sv) 1977-10-28 1982-04-01 Karbamidderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8202106A SE8202106L (sv) 1977-10-28 1982-04-01 Karbamidderivat

Country Status (15)

Country Link
US (1) US4234736A (sv)
JP (1) JPS5473754A (sv)
AU (2) AU522796B2 (sv)
BE (1) BE871584A (sv)
BR (1) BR7807115A (sv)
CA (2) CA1138334A (sv)
DE (1) DE2846945A1 (sv)
DK (1) DK481778A (sv)
FR (1) FR2407205A1 (sv)
GB (2) GB2087870B (sv)
IL (1) IL55774A (sv)
IT (1) IT1100904B (sv)
NL (1) NL7810562A (sv)
NZ (1) NZ188720A (sv)
SE (2) SE433304B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
FI801184A (fi) * 1979-04-24 1980-10-25 Hoffmann La Roche Foerfarande foer framstaellning av imidazolidinderivat
EP0091596B1 (de) * 1982-04-08 1991-09-11 Shell Internationale Researchmaatschappij B.V. Neue Hydantoine, ihre Herstellung und Verwendung
JP2791156B2 (ja) * 1988-08-23 1998-08-27 ザ ヌトラスウィート カンパニー 強力甘味料としての置換アリール尿素
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5670641A (en) * 1995-06-02 1997-09-23 American Cyanamid Company 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents
CA2413417A1 (en) * 2000-06-28 2002-01-03 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7087636B2 (en) 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
CA2550447A1 (en) * 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
NZ550102A (en) * 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
PT2656841T (pt) 2006-03-27 2016-09-28 Univ California Modulador do recetor de androgénios para o tratamento de cancro da próstata e doenças associadas ao recetor de androgénios
KR101600230B1 (ko) 2006-03-29 2016-03-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴티오히단토인 화합물
EP2220050A2 (en) 2007-10-26 2010-08-25 The Regents Of The University Of California Diarylhydantoin compounds as androgen receptor modulators
ES2668380T3 (es) 2010-02-16 2018-05-17 Aragon Pharmaceuticals, Inc. Moduladores de receptores de andrógenos y sus usos
SI3305285T1 (sl) 2012-09-26 2021-03-31 Aragon Pharmaceuticals, Inc. Anti-androgeni za zdravljenje proti kastraciji odpornega ne-metastatskega raka
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
JOP20200076A1 (ar) 2017-10-16 2020-04-30 Aragon Pharmaceuticals Inc مضادات أندروجين لعلاج سرطان البروستاتا غير النقيلي المقاوم للاستئصال

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629779A (sv) *
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
GB997037A (en) 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
IL31416A0 (en) 1968-02-19 1969-03-27 Bayer Ag 5-imino-2-oxo-imidazolidines,their preparation and use as herbicides
NL6904420A (sv) * 1968-03-28 1969-09-30
DK123717B (da) * 1968-11-25 1972-07-24 Sumitomo Chemical Co 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
US3676456A (en) * 1970-02-27 1972-07-11 Ciba Geigy Corp Derivatives of 3-aryl-5-alkylhydantoins
JPS5136332B1 (sv) * 1970-12-09 1976-10-07
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
IL45459A (en) * 1973-09-03 1978-01-31 Ciba Geigy Ag 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant

Also Published As

Publication number Publication date
AU4096278A (en) 1980-05-01
GB2087870A (en) 1982-06-03
DK481778A (da) 1979-04-29
GB2087870B (en) 1982-11-10
IT7829207A0 (it) 1978-10-27
NL7810562A (nl) 1979-05-02
FR2407205B1 (sv) 1982-12-31
AU8105182A (en) 1982-07-08
CA1137091A (en) 1982-12-07
GB2008101A (en) 1979-05-31
AU551161B2 (en) 1986-04-17
IL55774A (en) 1982-04-30
BE871584A (fr) 1979-04-27
US4234736A (en) 1980-11-18
CA1138334A (en) 1982-12-28
DE2846945A1 (de) 1979-05-03
SE433304B (sv) 1984-05-21
IT1100904B (it) 1985-09-28
BR7807115A (pt) 1979-05-15
FR2407205A1 (fr) 1979-05-25
NZ188720A (en) 1984-12-14
JPS5473754A (en) 1979-06-13
SE8202106L (sv) 1982-04-01
GB2008101B (en) 1982-09-08
IL55774A0 (en) 1978-12-17
AU522796B2 (en) 1982-06-24

Similar Documents

Publication Publication Date Title
SE7811193L (sv) Farmaceutiska preparat
IT7828704A0 (it) Ammidi.
FI782839A (fi) Pigmentdispersionsaemne
IT1109641B (it) Calzatura particolarmente scarpasportiva
TR19960A (tr) Feniluereler
DK153254C (da) Undervands-implosionsimpulsgenerator
DK460178A (da) Taerskeapparat til en mejetaersker
NO149299C (no) Elektrisk-celle
DK285778A (da) Maatte til baase
FI780783A (fi) Internt plasticerad polymerlatex
FI781594A (fi) Eldstad foer fast braensle
FI783491A (fi) Elastisk pappersmaskinfilt
FI782444A (fi) Baerhandtag foer behaollare
SE405069B (sv) Kledgalge
NO821514L (no) Fungicid preparat
FI781683A (fi) Kondensvattenkontroll foer en torkcylinder
PT68562A (pt) Drahtseil
FI780463A (fi) Tablettkross
DK241878A (da) Mejetaersker
SE7804558L (sv) Rontgenror
FI783955A (fi) Skruvloes tillslutningsklaemma
FI783369A (fi) Bedoevningstabletter
FI780086A (fi) Preparat foer tillfaongatagande av barkborrar speciellt av granbarkborrar
SE7813204L (sv) Snabbstal
NO151163C (no) Vignolaskinnepens

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7811193-7

Effective date: 19880627

Format of ref document f/p: F